In vitro evaluation of coating polymers for enteric coating and human ileal targeting

International Journal of Pharmaceutics

Volumn 298, Issue 1, 2005, Pages 26-37

  Huyghebaert, Nathalie ^a   Vermeire, An ^a   Remon, Jean Paul ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Aqoat; Coating; Crohn; Eudragit; Ileum; Thymidine

Indexed keywords

AMMONIA; AQOAT; CITRIC ACID TRIETHYL ESTER; DODECYL SULFATE SODIUM; EUDRAGIT; GLYCEROL STEARATE; MAGNESIUM STEARATE; POLYMER; POLYSORBATE 80; SEBACIC ACID DIBUTYL ESTER; TALC; THYMIDINE; UNCLASSIFIED DRUG;

ACIDITY; ARTICLE; CROHN DISEASE; DISSOLUTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG TARGETING; ENTERIC COATED TABLET; HIGH TEMPERATURE; HUMAN; ILEUM; PRIORITY JOURNAL; SMALL INTESTINE; THICKNESS;

HUMANS; HYDROGEN-ION CONCENTRATION; ILEUM; INTERLEUKIN-10; LACTOCOCCUS LACTIS; POLYMERS; POLYMETHACRYLIC ACIDS; RECOMBINANT PROTEINS; THYMIDINE;

EID: 20444447440     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2005.03.032     Document Type: Article

References (26)

1. B. Abrahamsson, M. Alpsten, U.E. Jonsson, P.J. Lundberg, A. Sandberg, M. Sundgren, A. Svenheden, and J. Tölli Gastro-intestinal transit of a multi-unit formulation (metoprolol CR/ZOK) and a non-disintegrating tablet with the emphasis on colon Int. J. Pharm. 140 1996 229 235
2. H. Both, K. Torp-Pederson, and S. Kreiner Clinical appearance at diagnosis of ulcerative colitis and Crohn's disease in a regional patient group Scand. J. Gastroent. 18 1983 987 991
3. C. Chen Recent advances in mucosal vaccine development J. Contr. Rel. 67 2000 117 128
4. S.S. Davis, J.G. Hardy, and J.W. Fara Transit of pharmaceutical dosage forms through the small intestine Gut 27 1986 886 892
5. D.F. Evans, G. Pye, R. Bramley, A.G. Clark, and T.J. Dyson Measurement of gastrointestinal pH profiles in normal ambulant human subjects Gut 29 1988 1035 1041
6. K. Ewe, S. Schartz, S. Petersen, and A.G. Press Inflammation does not decrease intraluminal pH in chronic inflammatory bowel disease Dig. Dis. Sci. 44 7 1999 1434 1439
7. J. Fallingborg, L.A. Christensen, M. Ingeman-Nielsen, B.A. Jacobsen, K. Abildgaard, and H.H. Rasmussen pH-profile and regional transit times of the normal gut measured by a radiotelemetry device Aliment. Pharmacol. Ther. 3 1989 605 613
8. J. Fallingborg, P. Pedersen, and A. Jacobsen Small intestinal transit time and intraluminal pH in ileocecal resected patients with Crohn's disease Dig. Dis. Sci. 43 4 1998 702 705
9. D.R. Friend Issues in oral administration of locally acting glucocorticosteroids for treatment of inflammatory bowel disease Aliment. Pharmacol. Ther. 12 1998 591 603
10. M.A. Frohoff-Hülsmann, A. Schmitz, and B.C. Lippold Aqueous ethyl cellulose dispersions containing plasticizers of different water solubility and hydropropyl methylcellulose as coating material for diffusion pellets. I. Drug release rates from coated pellets Int. J. Pharm. 777 1999 69 82
11. V.K. Gupta, T. Beckert, and J.C. Price A novel pH- and time-based multi-unit potential colonic drug delivery system. I. Development Int. J. Pharm. 213 2001 83 91
12. Harris, M., Ghebre-sellassie, I., 1997. Aqueous polymeric coating for modified release oral dosage forms. In: McGinity, J.W. (Ed.), Aqueous polymeric coatings for pharmaceutical dosage forms, New York, pp. 81-100.
13. Kato, T., Owen, L.R., 1994. Structure and function of intestinal mucosal epithelium. In: Ogra, P.L. (Ed.), Mucosal Immunology. San Diego, pp. 115-132.
14. ® S100 combination J. Contr. Rel. 58 1999 215 222
15. S. Klein, M.W. Rudolf, and J.B. Dressman Drug release characteristics of different mesalazine products using USP apparatus 3 to simulate passage through the GI tract Dis. Technol. 9 2002 6 12
16. N. Klijn, A. Weerkamp, and A. Vos Genetic Marking of Lactococcus lactis shows its survival in the human gastrointestinal tract Appl. Environ. Microbiol. 61 7 1995 2771 2774
17. Krämer, J., Blume, H., 1994. Biopharmaceutical aspects of multiparticulates. In: Ghebre-Sellassie, I. (Ed.), Multi-particulate Oral Drug Delivery. New York, pp. 307-323.
18. N. Mielcarek, S. Alonso, and C. Locht Nasal vaccination using live bacterial vectors Adv. Drug Del. Rev. 51 2001 55 69
19. T.C. Northfield, and I. McColl Postprandial concentrations of free and conjugated bile acids and conjugated bile acids down the length of the normal human small intestine Gut 14 1973 513 516
20. P. Nykänen, K. Krogars, M. Säkkinen, J. Heinämäki, H. Jürgensson, P. Veski, and M. Marvola Organic acids as excipients in matrix granules for colon-specific drug delivery Int. J. Pharm. 184 1999 251 261
21. A.G. Press, I.A. Hauptmann, L. Hauptmann, B. Fuchs, M. Fuchs, and K. Ewe Gastrointestinal pH profiles in patients with inflammatory bowel disease Aliment. Pharmacol. Ther. 12 1998 673 678
22. M.W. Rudolph, S. Klein, T.E. Beckert, H.U. Petereit, and J.B. Dressman A new 5-aminosalicylic acid multi-unit dosage form for the therapy of ulcerative colitis Eur. J. Pharm. Biopharm. 51 2001 183 190
23. Y. Sasaki, R. Hada, H. Nakajima, S. Fukuda, and A. Munakata Improved localising method of radiopill in measurements of entire gastrointestinal pH profiles: colonic luminal pH in normal subjects and patients with Crohn's disease Am. J. Gastroenterol. 92 1997 114 118
24. L. Steidler, S. Neirynck, N. Huyghebaert, V. Snoeck, A. Vermeire, B.M. Goddeeris, E. Cox, J.P. Remon, and E. Remaut Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin-10 Nat. Biotechnol. 21 7 2003 785 789
25. L. Steidler, W. Hans, L. Schotte, S. Neirynck, F. Obermeier, W. Falk, W. Fiers, and E. Remaut Treatment of Murine Colitis by Lactococcus lactis secreting interleukin-10 Science 289 2000 1352 1355
26. S.J.H. van Deventer, C.O. Elson, and R.N. Fedorak Multiple doses of intravenous interleukin-10 in steroid refractory Crohn's disease Gastroenterology 113 1997 383 389